1 ml/liter of each of a standard vitamin and a trace element solution). Batch cultures of 100 or 400ml in 250 or 1,000ml Erlenmeyer flasks, respectively, were incubated at 30°C on a rotary shaker at 160 rpm for 3~5 days. PI VO19grew in small lumps. It could readily be cultivated on technical media based on Probion (single cell protein prepared from Methylomonas clarae; Hoechst AG, Frankfurt), soy flour, skim milk powder (Humana Milchwerke, Her ford, FRG), or peanut meal. In shake cultures with 100 ml During our continuing search for new biologically active metabolites from myxobacteria1*, a new screening system using an MT-4cell culture assay with HIV-12'3) led to the discovery of the novel secondary metabolite, phenoxan ( Fig. 1 ). It was isolated from an acetone-extract of the cell mass of Polyangium spec, strain PI VO19 and purified as described elsewhere4*. The chemical and spectroscopic structure elucidation revealed phenoxan to be a new substituted oxazole-y-pyrone4) showing a structural similarity to the microbial metabolites aureothin5'6) and spectinabilin7). The cytotoxicity of phenoxan for different humanlymphoblastoid cell lines in vitro and its suppression of HIV-1infection in the MT-4 cell culture assay has been described2). In this paper we wish to report on the production of phenoxan, its antimicrobial activity, and on experiments with beef heart submitochondrial particles showing that phenoxan is a powerful inhibitor of the eukaryotic respiratory chain at the site of complex I, i.e., NADH: ubiquinone oxidoreductase.
The producing organism was Polyangium spec, strain PI VO19, isolated at the GBF in March 1988 from a soil sample collected in Ephesos, Turkey. The bacterium was initially cultivated in a lean standard nentone linuid medium(MD1I.m.: buffer 50 mM(pH 7.2), supplemented with standard vitamin and trace element solutions, 1 ml/liter each. Harvest wasat the end of the growth phase after about 4 days. b The concentration of phenoxan was determined by TLC-analysis. Aliquots of acetone extracts of the cell mass were chromatographed on thin-layer plates (silica-gel F254, Merck 5553) with toluene -methanol 85: 15 as the solvent. The plates were scanned at 250 nm using a Shimadzu CS 920 high speed scanner. The concentrations ofphenoxan were calculated from the peak areas of the phenoxan spots by comparison with those of the pure substance. 
mg of crystalline phenoxan4).
The antibiotic activity of phenoxan was determined by the agar diffusion test using paper discs. Phenoxanwas inactive against bacteria and yeasts but inhibited the growth of some fungi ( Table 2 ).
The MIC determined by the serial dilution assay with Ustilago maydis was 19ng/ml. To determine the mechanism of action of phenoxan we tested its influence on NADH oxidation of beef heart submitochondrial particles (SMP). The isolation and characterization of SMPas well as the performance of the experiments has been described previously8).
As Fig. 2 shows, phenoxan strongly inhibited NADHoxidation in SMP. At a concentration of 5.8nM (2.2ng/ml), an inhibition of 50% was achieved. The site of inhibition within the electron transport chain was investigated by difference spectroscopy8). Starting with fully oxidized cytochromes the cytochromes in front of the block become reduced in the presence of a physiological substrate, e.g., NADH, while those behind it remain oxidized. Treatment of SMP with 25 /ig/ml phenoxan completely inhibited reduction ofcytochrome aa3 (a band at 605 nm), cytochrome b (a band at 563 nm) and the cytochromes c+cx (a band at 554nm) by NADH (Fig. 3) . This indicated that the site of action of phenoxan is on the substrate site of cytochrome b. Cytochrome b of complex III can be reduced by A suspension of air-oxidized beef heart submitochondrial particles (SMP) was diluted to give a density of 3.2mg protein/ml. Cuvettes with an optical pathway of l cm were filled with 1.1 ml of the suspension and placed in the reference and sample position of a DW2A UV/VISdouble-beam spectrophotometer (American Instruments, Silver Springs, MD,USA). After the baseline (trace 1) had been recorded, phenoxan was added to the sample cuvette to a final concentration of 25 /ig/ml. After preincubation for two minutes, NADH(final concentration 2 mM)was added to the sample cuvette. Volumecorrections were performed in the reference cuvette. After two minutes the resulting difference spectrum was recorded (trace 2). As a control, the difference spectrum (reduced minus oxidized) of SMP reduced with NADHin the absence of phenoxan is also given (trace 3). A suspension of air-oxidized submitochondrial particles was diluted as described in Fig. 3 . The time course of cytochrome b reduction was measured by dual wavelength spectroscopy at the wavelength pair 563 minus 577nm. The suspension was preincubated as described in Fig. 3 . At the time indicated by the arrow either NADH(traces 1 and 2) or succinate (traces 3 and 4) were added to the sample and reference cuvettes, giving a final concentration of 2mM and 5mM, respectively. The sample cuvettes contained in addition phenoxan (traces 1 and 3) or methanol (traces 2 and 4). We therefore investigated the effect of the antibiotic on the reduction kinetics of cytochrome b using either NADH or succinate as the substrate. As Fig. 4 shows, phenoxan inhibited the reduction of cytochrome b only when NADH was the electron donor. This suggests that phenoxan, like myxalamids9), piericidin10) and aurachins A and B11}, specifically blocked the electron flow in complex I, i.e. NADH:ubiquinone oxidoreductase.
It may be mentioned that meanwhile we detected phenoxan also in cultures of further Polyangium strains, viz. PI 3890, PI 6245, PI 6353 and PI 6370.
